Jerusalem, Israel

S David Gertz


Average Co-Inventor Count = 5.8

ph-index = 2

Forward Citations = 48(Granted Patents)


Company Filing History:


Years Active: 1999-2002

Loading Chart...
2 patents (USPTO):Explore Patents

Title: S David Gertz: Innovator in Pharmaceutical Compounds

Introduction

S David Gertz is a prominent inventor based in Jerusalem, Israel. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that inhibit PDGF receptor kinase. With a total of 2 patents, his work has implications for treating various diseases.

Latest Patents

Gertz's latest patents include innovative compounds and methods for their preparation and use. One notable patent is focused on PDGF receptor kinase inhibitory compounds, detailing their preparation, purification, and pharmaceutical compositions. Another patent elaborates on the quinoxaline family of these compounds, emphasizing methods for their synthesis and slow-release pharmaceutical preparations. These inventions aim to provide effective treatments for both proliferative malignant and non-malignant diseases through local or systemic application.

Career Highlights

Throughout his career, S David Gertz has been associated with Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. His work has been instrumental in advancing the understanding and application of kinase inhibitors in medical treatments.

Collaborations

Gertz has collaborated with notable colleagues such as Alexander Levitzki and Aviv Gazit, contributing to the advancement of research in his field.

Conclusion

S David Gertz's innovative work in pharmaceutical compounds showcases his dedication to improving treatment options for various diseases. His contributions continue to influence the field of medical research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…